The GLP-1 Ripple: How Biomanufacturing is Rewiring the Global Sugar Grid

SEOUL, South Korea – October 16, 2026 — Energy transitions rarely happen in a vacuum. While policymakers obsess over the shift from fossil fuels to decentralized renewables, a parallel revolution is actively rewiring the human metabolic grid. The catalyst isn't a solar panel or a lithium-ion battery, but a class of pharmaceuticals: GLP-1 weight-loss medications. As millions of consumers fundamentally alter their caloric intake, the global food supply chain is being forced into a rapid, high-stakes reformulation.

At the center of this industrial pivot is Daesang Corporation. The South Korean food and biotechnology conglomerate announced today a staggering 450% year-over-year surge in its 2025 North American sales of allulose, a rare sugar that promises the functional benefits of traditional sucrose without the metabolic payload. Operating through its global sugar-reduction brand, Sweevero, Daesang has rapidly expanded its business-to-business network to approximately 30 corporate clients across the beverage, dairy, and confectionery sectors since entering the North American market in 2023.

This explosive growth is more than a successful product launch; it is a clear signal that the global ingredients sector is transitioning from legacy commodities to high-tech, bio-engineered solutions designed for a more resilient human energy system.

The GLP-1 Catalyst and the New Caloric Economy

The sudden ubiquity of GLP-1 receptor agonists has introduced an unprecedented demand shock to the consumer packaged goods (CPG) industry. As these medications suppress appetite and alter taste preferences, consumers are aggressively pivoting away from high-sugar foods. However, the demand for sweetness remains structurally embedded in Western diets.

This creates a complex engineering problem for food scientists. Traditional artificial sweeteners often fail to replicate the mouthfeel, browning properties, and bulking capabilities of sucrose. Enter allulose. Naturally occurring in trace amounts in figs and raisins, allulose is approximately 70% as sweet as conventional sugar but delivers only 10% of the calories. Crucially, it passes through the body without significantly spiking blood glucose levels.

For CPG manufacturers, allulose is the equivalent of a drop-in biofuel for the food industry—a way to decarbonize the caloric load without requiring a complete overhaul of the underlying product architecture. In carbonated beverages, it maintains a clean taste profile; in baked goods, it preserves moisture and enables the Maillard reaction necessary for browning.

Industry analysts note that the GLP-1 ripple effect is measurably driving the commercial adoption of rare sugars over conventional low-calorie sweeteners. Daesang's Sweevero brand, launched in 2024, was explicitly designed to capitalize on this shift. Rather than merely acting as a bulk supplier, the company provides customized blends and taste modulation technologies, effectively serving as an outsourced research and development arm for North American food manufacturers scrambling to reformulate their portfolios.

From Legacy Fermentation to High-Tech Bio-Industrial Power

Daesang's aggressive push into rare sugars marks a fascinating corporate evolution. Founded in 1956, the company is globally recognized for its traditional fermented foods, operating powerhouse consumer brands like Jongga kimchi. Yet, beneath its consumer-facing exterior lies a sophisticated industrial biotechnology engine.

The transition from traditional fermentation to advanced bio-manufacturing requires immense capital and proprietary intellectual property. In July 2023, Daesang invested roughly KRW 30 billion (approximately $23.4 million) to bring online a dedicated allulose production facility at its starch and sweetener plant in Gunsan, South Korea. Today, this facility stands as the country's largest allulose plant, serving as the critical infrastructure for the company's North American export strategy.

But the rare sugar market is not without its systemic risks. The global allulose sector is currently experiencing a massive capacity glut. Driven by optimistic demand forecasts, global production capacity skyrocketed from roughly 15,000 tonnes in 2021 to an estimated 128,000 tonnes in 2025. However, actual global consumption hovered around 20,000 tonnes last year. This severe overcapacity—amounting to a demand-to-capacity ratio of just over 15%—has triggered intense price competition.

To insulate itself from this commoditization trap, Daesang relies heavily on its proprietary IP. The company holds numerous patents covering the specific enzymes used in allulose synthesis, including a recently filed 2025 patent for an optimized allulose syrup composition. By leveraging these proprietary enzymes and focusing on high-margin, customized Sweevero solutions rather than raw commodity sales, Daesang is attempting to build a resilient economic moat against regional rivals like Samyang Corporation—which recently completed a 13,000-tonne facility in Ulsan—and global ingredient giants such as Tate & Lyle and Ingredion.

Navigating the Global Regulatory Bottleneck

While technological capability dictates production, geopolitical and regulatory frameworks dictate market access. Daesang's 450% growth narrative is currently deeply concentrated in North America, heavily subsidized by a favorable regulatory environment. The U.S. Food and Drug Administration (FDA) grants allulose Generally Recognized as Safe (GRAS) status and importantly allows it to be excluded from the "Total Sugars" and "Added Sugars" lines on nutrition facts panels. This regulatory green light has been the primary engine for North American adoption.

Expanding this success globally, however, presents a fragmented regulatory puzzle. Daesang has explicitly targeted Europe, Latin America, Japan, and Southeast Asia for its next phase of growth. Yet, the European Union and the United Kingdom treat allulose under strict Novel Food frameworks. The European Food Safety Authority (EFSA) approval process is notoriously lengthy and complex, creating a significant bottleneck that forces ingredient suppliers to temper their European expansion timelines.

Conversely, the Asian market is rapidly opening up. In July 2025, China's National Health Commission officially approved allulose as a new food ingredient, unlocking a massive consumer base. Daesang is already maneuvering to capture this demand, with its Southeast Asian subsidiaries having posted 790 billion KRW in sales in 2025 and targeting 1 trillion KRW by 2030.

Engineering a Resilient Supply Chain

As the regulatory landscape slowly harmonizes, the next frontier for Daesang is supply chain resilience. Relying solely on the Gunsan facility for global exports exposes the company to shipping vulnerabilities and geopolitical trade friction. To mitigate this, Daesang is actively exploring localized production hubs outside of South Korea, evaluating potential manufacturing sites in key Western markets to shorten supply lines and ensure uninterrupted delivery to its growing B2B client base.

"As health awareness and interest in reducing sugar intake grow in North America, demand for allulose is rising rapidly, and its use is expanding into more food categories," stated Hyo-hoon Lee, head of Ingredient Marketing at Daesang, in the company's recent announcement. "Through Sweevero, we aim to go beyond supplying allulose by helping customers address the challenges of sugar reduction, particularly in taste and product quality. By combining our production capabilities with customized solutions and taste modulation technologies, we will strengthen partnerships with global food companies and expand our presence in key markets."

The global power grid is defined by how we generate, distribute, and consume energy. The food system operates on the exact same principles. As the world transitions toward a lower-calorie, higher-efficiency metabolic future, the ingredient suppliers who can master the complex biomanufacturing required to produce rare sugars at scale will dictate the terms of the new caloric economy. Daesang's rapid ascent in North America proves that the race to rewire the global sugar grid has officially begun.